Individual Technologies

Individual Technologies

Due to the diverse nature of the work conducted by Dstl not all developments can be applied to our defined segments.

Brief summaries of our specialist solutions are given below, and you can also download information sheets in pdf format (just enter your email address when prompted to initiate the required document download).

Humane Rodenticide

The £200m rodenticide manufacturing market is dominated by products based upon anticoagulants.  However, due to issues of concern regarding humaneness, toxicity (resistance) and safety there is increasing pressure upon the industry to develop new products.

Download Full Details

Non formaldehyde toxoiding

Scientists at the Defence Science and Technology Laboratory (Dstl) in the UK have developed a method to treat a toxin to produce a toxoid for use in vaccines that does not involve the use of formaldehyde. These toxoids are more stable, quicker to produce and avoid the toxicity associated with formaldehyde.

Download Full Details